Compositions and methods for treating dysregulated wound healing
AssigneeThe Regents of the University of California
InventorArjun Deb
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to compositions and methods for treating a dysregulated wound healing, for improving wound healing, for inhibiting scar formation, for treating a subject with Ehlers Danlos syndrome (EDS), and for treating a subject diagnosed with a heart attack. The present disclosure further relates to compositions and methods for predicting future cardiac risk in a subject who has suffered a heart attack, and predicting risk of future cardiac disease in a subject suffering a heart attack.
Claims23
A method for treating a dysregulated wound healing in a subject, comprising administering to the subject an inhibitor of integrin.
6-26. (canceled)
A method of treating a subject with Ehlers Danlos syndrome (EDS), comprising administering to the subject an inhibitor of integrin.
41-75. (canceled)
A method for treating myocardial infarction in a subject, comprising administering to the subject an inhibitor of integrin.
77-87. (canceled)
Dependencies are inferred from the claim text.